Lorenza Mittempergher (L Mittempergher)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Positive Breast Cancer

Sentinel Lymph Node

Epidermal Growth Factor Receptor

Top Venues

NPJ breast cancer

JCO precision oncology

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Marte C Liefaard, A van der Voort, M van Seijen, Bram Thijssen, J Sanders, S Vonk, Lorenza Mittempergher, R Bhaskaran, Linda de Munck, A E van Leeuwen-Stok, Roberto Salgado, Hugo Mark Horlings, Esther H Lips, G S Sonke
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade. NPJ breast cancer 10 (1) (2024)
Marte C Liefaard, A van der Voort, M van Seijen, Bram Thijssen, J Sanders, S Vonk, Lorenza Mittempergher, R Bhaskaran, Linda de Munck, A E van Leeuwen-Stok, Roberto Salgado, Hugo Mark Horlings, Esther H Lips, G S Sonke
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade. NPJ breast cancer 10 (1) (2024)
Marte C Liefaard, A van der Voort, M van Seijen, Bram Thijssen, J Sanders, S Vonk, Lorenza Mittempergher, R Bhaskaran, Linda de Munck, A E van Leeuwen-Stok, Roberto Salgado, Hugo Mark Horlings, Esther H Lips, G S Sonke
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade. NPJ breast cancer 10 (1) (2024)
Ian E Krop, Lorenza Mittempergher, Joseph N Paulson, Fabrice Andre, Hervé R Bonnefoi, Sherene Loi, Sibylle Loibl, Richard D Gelber, Carmela Caballero, Rajith Bhaskaran, Christa Dreezen, Andrea R Menicucci, René Bernards, Laura J van 't Veer, Martine J Piccart
Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial. JCO precision oncology 8 (2024)
Marte C Liefaard, A van der Voort, M van Seijen, Bram Thijssen, J Sanders, S Vonk, Lorenza Mittempergher, R Bhaskaran, Linda de Munck, A E van Leeuwen-Stok, Roberto Salgado, Hugo Mark Horlings, Esther H Lips, G S Sonke
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade. NPJ breast cancer 10 (1) (2024)
Tessa G Steenbruggen, Denise M Wolf, Bram Thijssen, Joyce Sanders, Sten Cornelissen, Roberto Salgado, Lorenza Mittempergher, Rajith Bhaskaran, Annegien Broeks, Esther H Lips, Sabine Siesling, Gabe S Sonke, Hugo Mark Horlings, Laura J van 't Veer
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide Cohort. JCO precision oncology 7 (2023)
Midas M Kuilman, Architha Ellappalayam, Andrei Barcaru, Josien C Haan, Rajith Bhaskaran, Diederik Wehkamp, Andrea R Menicucci, William M Audeh, Lorenza Mittempergher, Annuska M Glas
BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance. Breast cancer research and treatment 195 (3) (2022)
Lorenza Mittempergher, Anna M Piskorz, Astrid J Bosma, Magali Michaut, G Bea A Wisman, Roelof J C Kluin, Marja Nieuwland, Wim Brugman, Kevin J W van der Ven, Francesco Marass, James Morris, Nitzan Rosenfeld, Mercedes Jimenez-Linan, Steven de Jong, Ate G J van der Zee, James D Brenton, René Bernards
Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene. PloS one 15 (7) (2020)